Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Scope of the Report:
The classification of Anthrax Vaccines includes Live Vaccines and Cell free PA Vaccines, and the revenue proportion of Live Vaccines in 2016 is about 43%.
Anthrax Vaccines are widely used for human and animal. The most proportion of Anthrax Vaccines is used for animal, and the consumption proportion is about 95.1% in 2016.
South America region is the largest supplier of Anthrax Vaccines, with a production market share nearly 34.7% in 2016. Europe is the second largest supplier of Anthrax Vaccines, enjoying production market share nearly 17.6% in 2016.
South America is the largest sales place, with a sales market share nearly 39.3% in 2016. Following South America, Europe is the second largest sales place with the sales market share of 19.1%.
Along with the development of China 's Agricultural technology, there is a lot Chinese local manufacturer can produce Anthrax Vaccines, with the increasing demand, more and more manufactures will go into Anthrax Vaccines industry.
Market competition is intense. Emergent BioSolutions is the major manufacturer of Anthrax Vaccines used for human, Merial, Merck, Zoetis, Bayer Sanidad Animal,Colorado Serum, etc. are is the major manufacturer of Anthrax Vaccines used for animal, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Anthrax Vaccines is expected to grow at a CAGR of roughly 7.5% over the next five years, will reach 720 million US$ in 2024, from 500 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Anthrax Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Emergent BioSolutions
- Merial
- Merck
- Zoetis
- Bayer Sanidad Animal
- Colorado Serum
- PharmAthene
- Tiankang
- Biogénesis-Bago
- CAVAC
- Rosenbusch
- Agrovet
- Vecol
- CVCRI
- IVPM
- Prondil
- CDV
- Indian Immunologicals
- Botswana Vaccine Institute
- Ceva Santé Animale
- Intervac
- JOVAC
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Live Vaccines
- Cell free PA Vaccines
Market Segment by Applications, can be divided into
- Human Use
- Animal Use
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anthrax Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anthrax Vaccines, with price, sales, revenue and global market share of Anthrax Vaccines in 2017 and 2018.
Chapter 3, the Anthrax Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anthrax Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Anthrax Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Anthrax Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Global Anthrax Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
Table of Contents
1 Market Overview
1.1 Anthrax Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Live Vaccines
1.2.2 Cell free PA Vaccines
1.3 Market Analysis by Applications
1.3.1 Human Use
1.3.2 Animal Use
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Emergent BioSolutions
2.1.1 Business Overview
2.1.2 Anthrax Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merial
2.2.1 Business Overview
2.2.2 Anthrax Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merial Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck
2.3.1 Business Overview
2.3.2 Anthrax Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Zoetis
2.4.1 Business Overview
2.4.2 Anthrax Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bayer Sanidad Animal
2.5.1 Business Overview
2.5.2 Anthrax Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Colorado Serum
2.6.1 Business Overview
2.6.2 Anthrax Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 PharmAthene
2.7.1 Business Overview
2.7.2 Anthrax Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Tiankang
2.8.1 Business Overview
2.8.2 Anthrax Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Biogénesis-Bago
2.9.1 Business Overview
2.9.2 Anthrax Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 CAVAC
2.10.1 Business Overview
2.10.2 Anthrax Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Rosenbusch
2.11.1 Business Overview
2.11.2 Anthrax Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Rosenbusch Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Agrovet
2.12.1 Business Overview
2.12.2 Anthrax Vaccines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Vecol
2.13.1 Business Overview
2.13.2 Anthrax Vaccines Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 CVCRI
2.14.1 Business Overview
2.14.2 Anthrax Vaccines Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 IVPM
2.15.1 Business Overview
2.15.2 Anthrax Vaccines Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Prondil
2.16.1 Business Overview
2.16.2 Anthrax Vaccines Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 CDV
2.17.1 Business Overview
2.17.2 Anthrax Vaccines Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 CDV Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Indian Immunologicals
2.18.1 Business Overview
2.18.2 Anthrax Vaccines Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Botswana Vaccine Institute
2.19.1 Business Overview
2.19.2 Anthrax Vaccines Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.20 Ceva Santé Animale
2.20.1 Business Overview
2.20.2 Anthrax Vaccines Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.21 Intervac
2.21.1 Business Overview
2.2.2 Anthrax Vaccines Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.22 JOVAC
2.22.1 Business Overview
2.22.2 Anthrax Vaccines Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anthrax Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Anthrax Vaccines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Anthrax Vaccines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Anthrax Vaccines Manufacturer Market Share in 2018
3.3.2 Top 6 Anthrax Vaccines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Anthrax Vaccines Market Analysis by Regions
4.1 Global Anthrax Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Anthrax Vaccines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Anthrax Vaccines Revenue and Market Share by Regions (2014-2019)
4.2 North America Anthrax Vaccines Sales and Growth Rate (2014-2019)
4.3 Europe Anthrax Vaccines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Anthrax Vaccines Sales and Growth Rate (2014-2019)
4.5 South America Anthrax Vaccines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Anthrax Vaccines Sales and Growth Rate (2014-2019)
5 North America Anthrax Vaccines by Country
5.1 North America Anthrax Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Anthrax Vaccines Sales and Market Share by Country (2014-2019)
5.1.2 North America Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
5.2 United States Anthrax Vaccines Sales and Growth Rate (2014-2019)
5.3 Canada Anthrax Vaccines Sales and Growth Rate (2014-2019)
5.4 Mexico Anthrax Vaccines Sales and Growth Rate (2014-2019)
6 Europe Anthrax Vaccines by Country
6.1 Europe Anthrax Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Anthrax Vaccines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
6.2 Germany Anthrax Vaccines Sales and Growth Rate (2014-2019)
6.3 UK Anthrax Vaccines Sales and Growth Rate (2014-2019)
6.4 France Anthrax Vaccines Sales and Growth Rate (2014-2019)
6.5 Russia Anthrax Vaccines Sales and Growth Rate (2014-2019)
6.6 Italy Anthrax Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Anthrax Vaccines by Country
7.1 Asia-Pacific Anthrax Vaccines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Anthrax Vaccines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
7.2 China Anthrax Vaccines Sales and Growth Rate (2014-2019)
7.3 Japan Anthrax Vaccines Sales and Growth Rate (2014-2019)
7.4 Korea Anthrax Vaccines Sales and Growth Rate (2014-2019)
7.5 India Anthrax Vaccines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Anthrax Vaccines Sales and Growth Rate (2014-2019)
8 South America Anthrax Vaccines by Country
8.1 South America Anthrax Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Anthrax Vaccines Sales and Market Share by Country (2014-2019)
8.1.2 South America Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Anthrax Vaccines Sales and Growth Rate (2014-2019)
8.3 Argentina Anthrax Vaccines Sales and Growth Rate (2014-2019)
8.4 Colombia Anthrax Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Anthrax Vaccines by Countries
9.1 Middle East and Africa Anthrax Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Anthrax Vaccines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Anthrax Vaccines Sales and Growth Rate (2014-2019)
9.3 Turkey Anthrax Vaccines Sales and Growth Rate (2014-2019)
9.4 Egypt Anthrax Vaccines Sales and Growth Rate (2014-2019)
9.5 Nigeria Anthrax Vaccines Sales and Growth Rate (2014-2019)
9.6 South Africa Anthrax Vaccines Sales and Growth Rate (2014-2019)
10 Global Anthrax Vaccines Market Segment by Type
10.1 Global Anthrax Vaccines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Anthrax Vaccines Sales and Market Share by Type (2014-2019)
10.1.2 Global Anthrax Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Live Vaccines Sales Growth and Price
10.2.1 Global Live Vaccines Sales Growth (2014-2019)
10.2.2 Global Live Vaccines Price (2014-2019)
10.3 Cell free PA Vaccines Sales Growth and Price
10.3.1 Global Cell free PA Vaccines Sales Growth (2014-2019)
10.3.2 Global Cell free PA Vaccines Price (2014-2019)
11 Global Anthrax Vaccines Market Segment by Application
11.1 Global Anthrax Vaccines Sales Market Share by Application (2014-2019)
11.2 Human Use Sales Growth (2014-2019)
11.3 Animal Use Sales Growth (2014-2019)
12 Anthrax Vaccines Market Forecast (2019-2024)
12.1 Global Anthrax Vaccines Sales, Revenue and Growth Rate (2019-2024)
12.2 Anthrax Vaccines Market Forecast by Regions (2019-2024)
12.2.1 North America Anthrax Vaccines Market Forecast (2019-2024)
12.2.2 Europe Anthrax Vaccines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Anthrax Vaccines Market Forecast (2019-2024)
12.2.4 South America Anthrax Vaccines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Anthrax Vaccines Market Forecast (2019-2024)
12.3 Anthrax Vaccines Market Forecast by Type (2019-2024)
12.3.1 Global Anthrax Vaccines Sales Forecast by Type (2019-2024)
12.3.2 Global Anthrax Vaccines Market Share Forecast by Type (2019-2024)
12.4 Anthrax Vaccines Market Forecast by Application (2019-2024)
12.4.1 Global Anthrax Vaccines Sales Forecast by Application (2019-2024)
12.4.2 Global Anthrax Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anthrax Vaccines Picture
Table Product Specifications of Anthrax Vaccines
Figure Global Sales Market Share of Anthrax Vaccines by Types in 2018
Table Anthrax Vaccines Types for Major Manufacturers
Figure Live Vaccines Picture
Figure Cell free PA Vaccines Picture
Figure Anthrax Vaccines Sales Market Share by Applications in 2018
Figure Human Use Picture
Figure Animal Use Picture
Figure United States Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure France Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure UK Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure China Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure India Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Anthrax Vaccines Revenue (Value) and Growth Rate (2014-2024)
Table Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table Emergent BioSolutions Anthrax Vaccines Type and Applications
Table Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merial Basic Information, Manufacturing Base and Competitors
Table Merial Anthrax Vaccines Type and Applications
Table Merial Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Anthrax Vaccines Type and Applications
Table Merck Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Zoetis Basic Information, Manufacturing Base and Competitors
Table Zoetis Anthrax Vaccines Type and Applications
Table Zoetis Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Sanidad Animal Basic Information, Manufacturing Base and Competitors
Table Bayer Sanidad Animal Anthrax Vaccines Type and Applications
Table Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Colorado Serum Basic Information, Manufacturing Base and Competitors
Table Colorado Serum Anthrax Vaccines Type and Applications
Table Colorado Serum Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table PharmAthene Basic Information, Manufacturing Base and Competitors
Table PharmAthene Anthrax Vaccines Type and Applications
Table PharmAthene Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Tiankang Basic Information, Manufacturing Base and Competitors
Table Tiankang Anthrax Vaccines Type and Applications
Table Tiankang Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biogénesis-Bago Basic Information, Manufacturing Base and Competitors
Table Biogénesis-Bago Anthrax Vaccines Type and Applications
Table Biogénesis-Bago Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CAVAC Basic Information, Manufacturing Base and Competitors
Table CAVAC Anthrax Vaccines Type and Applications
Table CAVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Rosenbusch Basic Information, Manufacturing Base and Competitors
Table Rosenbusch Anthrax Vaccines Type and Applications
Table Rosenbusch Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Agrovet Basic Information, Manufacturing Base and Competitors
Table Agrovet Anthrax Vaccines Type and Applications
Table Agrovet Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Vecol Basic Information, Manufacturing Base and Competitors
Table Vecol Anthrax Vaccines Type and Applications
Table Vecol Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CVCRI Basic Information, Manufacturing Base and Competitors
Table CVCRI Anthrax Vaccines Type and Applications
Table CVCRI Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table IVPM Basic Information, Manufacturing Base and Competitors
Table IVPM Anthrax Vaccines Type and Applications
Table IVPM Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Prondil Basic Information, Manufacturing Base and Competitors
Table Prondil Anthrax Vaccines Type and Applications
Table Prondil Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CDV Basic Information, Manufacturing Base and Competitors
Table CDV Anthrax Vaccines Type and Applications
Table CDV Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table Indian Immunologicals Anthrax Vaccines Type and Applications
Table Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Botswana Vaccine Institute Basic Information, Manufacturing Base and Competitors
Table Botswana Vaccine Institute Anthrax Vaccines Type and Applications
Table Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table Ceva Santé Animale Anthrax Vaccines Type and Applications
Table Ceva Santé Animale Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Intervac Basic Information, Manufacturing Base and Competitors
Table Intervac Anthrax Vaccines Type and Applications
Table Intervac Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table JOVAC Basic Information, Manufacturing Base and Competitors
Table JOVAC Anthrax Vaccines Type and Applications
Table JOVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Anthrax Vaccines Sales by Manufacturer (2017-2018)
Figure Global Anthrax Vaccines Sales Market Share by Manufacturer in 2017
Figure Global Anthrax Vaccines Sales Market Share by Manufacturer in 2018
Table Global Anthrax Vaccines Revenue by Manufacturer (2017-2018)
Figure Global Anthrax Vaccines Revenue Market Share by Manufacturer in 2017
Figure Global Anthrax Vaccines Revenue Market Share by Manufacturer in 2018
Figure Top 3 Anthrax Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Anthrax Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Global Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Global Anthrax Vaccines Revenue and Growth Rate (2014-2019)
Table Global Anthrax Vaccines Sales by Regions (2014-2019)
Table Global Anthrax Vaccines Sales Market Share by Regions (2014-2019)
Table Global Anthrax Vaccines Revenue by Regions (2014-2019)
Figure Global Anthrax Vaccines Revenue Market Share by Regions in 2014
Figure Global Anthrax Vaccines Revenue Market Share by Regions in 2018
Figure North America Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Europe Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure South America Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure North America Anthrax Vaccines Revenue and Growth Rate (2014-2019)
Table North America Anthrax Vaccines Sales by Countries (2014-2019)
Table North America Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Figure North America Anthrax Vaccines Sales Market Share by Countries in 2014
Figure North America Anthrax Vaccines Sales Market Share by Countries in 2018
Table North America Anthrax Vaccines Revenue by Countries (2014-2019)
Table North America Anthrax Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America Anthrax Vaccines Revenue Market Share by Countries in 2014
Figure North America Anthrax Vaccines Revenue Market Share by Countries in 2018
Figure United States Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Canada Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Mexico Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Europe Anthrax Vaccines Revenue and Growth Rate (2014-2019)
Table Europe Anthrax Vaccines Sales by Countries (2014-2019)
Table Europe Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Table Europe Anthrax Vaccines Revenue by Countries (2014-2019)
Figure Europe Anthrax Vaccines Revenue Market Share by Countries in 2017
Figure Europe Anthrax Vaccines Revenue Market Share by Countries in 2018
Figure Germany Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure UK Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure France Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Russia Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Italy Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Anthrax Vaccines Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Anthrax Vaccines Sales by Countries (2014-2019)
Table Asia-Pacific Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Anthrax Vaccines Sales Market Share by Countries 2018
Table Asia-Pacific Anthrax Vaccines Revenue by Countries (2014-2019)
Figure Asia-Pacific Anthrax Vaccines Revenue Market Share by Countries 2018
Figure China Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Japan Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Korea Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure India Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Southeast Asia Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure South America Anthrax Vaccines Revenue and Growth Rate (2014-2019)
Table South America Anthrax Vaccines Sales by Countries (2014-2019)
Table South America Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Figure South America Anthrax Vaccines Sales Market Share by Countries in 2018
Table South America Anthrax Vaccines Revenue by Countries (2014-2019)
Table South America Anthrax Vaccines Revenue Market Share by Countries (2014-2019)
Figure South America Anthrax Vaccines Revenue Market Share by Countries in 2018
Figure Brazil Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Argentina Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Colombia Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Anthrax Vaccines Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Anthrax Vaccines Sales by Countries (2014-2019)
Table Middle East and Africa Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Anthrax Vaccines Sales Market Share by Countries in 2018
Table Middle East and Africa Anthrax Vaccines Revenue by Countries (2014-2019)
Table Middle East and Africa Anthrax Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anthrax Vaccines Revenue Market Share by Countries in 2014
Figure Middle East and Africa Anthrax Vaccines Revenue Market Share by Countries in 2018
Figure Saudi Arabia Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure UAE Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Egypt Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure Nigeria Anthrax Vaccines Sales and Growth Rate (2014-2019)
Figure South Africa Anthrax Vaccines Sales and Growth Rate (2014-2019)
Table Global Anthrax Vaccines Sales by Type (2014-2019)
Table Global Anthrax Vaccines Sales Share by Type (2014-2019)
Table Global Anthrax Vaccines Revenue by Type (2014-2019)
Table Global Anthrax Vaccines Revenue Share by Type (2014-2019)
Figure Global Live Vaccines Sales Growth (2014-2019)
Figure Global Live Vaccines Price (2014-2019)
Figure Global Cell free PA Vaccines Sales Growth (2014-2019)
Figure Global Cell free PA Vaccines Price (2014-2019)
Table Global Anthrax Vaccines Sales by Application (2014-2019)
Table Global Anthrax Vaccines Sales Share by Application (2014-2019)
Figure Global Animal Use Sales Growth (2014-2019)
Figure Global Anthrax Vaccines Sales, Revenue and Growth Rate (2019-2024)
Table Global Anthrax Vaccines Sales Forecast by Regions (2019-2024)
Table Global Anthrax Vaccines Market Share Forecast by Regions (2019-2024)
Figure North America Sales Anthrax Vaccines Market Forecast (2019-2024)
Figure Europe Sales Anthrax Vaccines Market Forecast (2019-2024)
Figure Asia-Pacific Sales Anthrax Vaccines Market Forecast (2019-2024)
Figure South America Sales Anthrax Vaccines Market Forecast (2019-2024)
Figure Middle East and Africa Sales Anthrax Vaccines Market Forecast (2019-2024)
Table Global Anthrax Vaccines Sales Forecast by Type (2019-2024)
Table Global Anthrax Vaccines Market Share Forecast by Type (2019-2024)
Table Global Anthrax Vaccines Sales Forecast by Application (2019-2024)
Table Global Anthrax Vaccines Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
